Vital Chemtech promoter confirms no encumbrance over shares in FY26

Sangeeta Vipul Bhatt, a promoter of Vital Chemtech Limited , has confirmed that no new encumbrance was created over the shares held by the promoter group during the financial year 2025-26. The declaration was submitted to the National Stock Exchange in compliance with regulatory requirements.

The filing was made under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. Bhatt stated that none of the promoters, the Promoter Group, or persons acting in concert have created any encumbrance over the shares of Vital Chemtech Limited, other than those already disclosed, directly or indirectly.

The confirmation covers the entire financial year 2025-26. The declaration is addressed to the Audit Committee of Vital Chemtech Limited and was submitted to the exchanges on April 04, 2026.

Key Details of the Filing

Aspect	Details
Regulation	Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011
Declarant	Sangeeta Vipul Bhatt, Promoter
Company	Vital Chemtech Limited
Period Covered	Financial Year 2025-26
Status	No encumbrance other than already disclosed

Promoters and Promoter Group

The declaration covers 29 entities, including promoters Vipul Bhatt and Sangeeta Vipul Bhatt, and 27 members of the Promoter Group such as Vital Alkoxide Private Limited, Vital Wellness Limited, and Vital Synthesis Limited.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.79%	+16.53%	-1.96%	-3.51%	-13.32%	-66.28%

Vital Chemtech Limited reported a 74.1% year-on-year decline in profit after tax (PAT) to ₹1.0 crore for the financial year ended March 31, 2026 (FY26), impacted by investments in its subsidiaries. Revenue from operations for FY26 decreased by 5.6% to ₹126.4 crore, compared to ₹133.9 crore in FY25. The company disclosed its audited standalone and consolidated financial results for Q4FY26 and FY26 on June 1, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

For the quarter ended March 31, 2026 (Q4FY26), revenue remained stable at ₹35.1 crore. EBITDA for the quarter rose 39.7% to ₹4.0 crore, with margins expanding by 320 basis points to 11.3%. However, Q4 PAT declined by 28.2% to ₹0.8 crore, with margins contracting by 95 basis points to 2.4%. The statutory auditors, M/s Abhishek Kumar & Associates, issued an unmodified opinion on the financial statements.

Financial Performance Summary

₹ crores unless otherwise mentioned	Q4 FY26	Q4 FY25	YoY change (%)	FY26	FY25	YoY change (%)
Revenue from operations	35.1	35.1	0.2%	126.4	133.9	-5.6%
EBITDA	4.0	2.8	39.7%	10.0	10.6	-5.6%
EBITDA Margin	11.3%	8.1%	320 bps	7.9%	7.9%	0 bps
Profit after tax	0.8	1.2	-28.2%	1.0	4.0	-74.1%
PAT Margin	2.4%	3.3%	-95 bps	0.8%	3.0%	-215 bps
EPS (₹)	0.4	0.5	-26.5%	0.4	1.7	-74.1%

Operational Highlights

The decline in profitability was primarily attributable to investments made in two subsidiaries, Vital Synthesis Limited and Vital Alkoxides Private Limited. Vital Synthesis Limited commenced commercial operations in Q3 FY26 and is witnessing a gradual scale-up in customer acceptance. Vital Alkoxides Private Limited delivered strong business momentum during FY26, achieving approximately 63% YoY revenue growth.

Vipul Bhatt, Chairman and Managing Director, stated that the company focused on strengthening its business foundation through strategic investments and operational improvements. He noted that while investments in subsidiaries impacted short-term profitability, they are expected to strengthen the group's growth platform and diversification strategy. The company operates a fully automated manufacturing complex at Dahej, Gujarat, with a cumulative installed capacity of 33,192 MT.